Magnostics Ltd is a bionanotechnology SME founded on successive research investment by NASA and the EU.
We produce the high performance Aurosphere®
magnetic nanoparticles, which enable rapid, efficient separations of proteins, nucleic acids, and cells,
and the development of a highly specific assay for Acute Mesenteric Ischemia.
Our Products
Magnostics supplies the Aurosphere® beads to the biotechnology and MedTech
industry for in vitro diagnostics (IVD), bioseparations and high throughput screening (HTS).
We seek medical and business partnerships for commercialization of our products. Magnostics is an ISO13485
compliant supplier of magnetic beads for diagnostic and bioseparation.
Research and Development
Aurosphere®beads have a high rate and efficiency of separation of specific biomarkers
with advanced chemistries. In collaboration with our medical partners, we have developed a novel assay
for Acute Mesenteric Ischemia that promises to improved the quality of care for this rare but deadly disease.
This screening test could save up to 75% of AMI patients if it is deployed in an emergency care clinical laboratory.